.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Express Scripts
Mallinckrodt
Cantor Fitzgerald
Cerilliant
Baxter
Cipla
Harvard Business School
Colorcon
Federal Trade Commission

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018961

« Back to Dashboard

NDA 018961 describes CHROMIC CHLORIDE IN PLASTIC CONTAINER, which is a drug marketed by Hospira and is included in one NDA. It is available from one supplier. Additional details are available on the CHROMIC CHLORIDE IN PLASTIC CONTAINER profile page.

The generic ingredient in CHROMIC CHLORIDE IN PLASTIC CONTAINER is chromic chloride. One supplier is listed for this compound. Additional details are available on the chromic chloride profile page.

Summary for 018961

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 018961

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHROMIC CHLORIDE IN PLASTIC CONTAINER chromic chloride INJECTABLE;INJECTION 018961 NDA Hospira, Inc. 0409-4093 0409-4093-10 25 VIAL, PLASTIC in 1 TRAY (0409-4093-10) > 10 mL in 1 VIAL, PLASTIC (0409-4093-09)
CHROMIC CHLORIDE IN PLASTIC CONTAINER chromic chloride INJECTABLE;INJECTION 018961 NDA Hospira, Inc. 0409-4093 0409-4093-01 25 VIAL, PLASTIC in 1 TRAY (0409-4093-01) > 10 mL in 1 VIAL, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 0.004MG CHROMIUM/ML
Approval Date:Jun 26, 1986TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Cipla
Chubb
Express Scripts
Johnson and Johnson
AstraZeneca
Cantor Fitzgerald
Fish and Richardson
Citi
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot